Seek Returns logo

BDX vs. ORCL: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at BDX and ORCL, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolBDXORCL
Company NameBecton, Dickinson and CompanyOracle Corporation
CountryUnited StatesUnited States
GICS SectorHealth CareInformation Technology
GICS IndustryHealth Care Equipment & SuppliesSoftware
Market Capitalization55.59 billion USD822.82 billion USD
ExchangeNYSENYSE
Listing DateFebruary 21, 1973March 12, 1986
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of BDX and ORCL by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

BDX vs. ORCL: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolBDXORCL
5-Day Price Return1.22%-0.05%
13-Week Price Return10.50%22.40%
26-Week Price Return-12.48%110.33%
52-Week Price Return-18.33%69.81%
Month-to-Date Return3.61%2.63%
Year-to-Date Return-14.52%73.21%
10-Day Avg. Volume1.37M23.30M
3-Month Avg. Volume2.38M19.31M
3-Month Volatility27.16%81.79%
Beta0.261.65

Profitability

Return on Equity (TTM)

BDX

6.31%

Health Care Equipment & Supplies Industry

Max
29.93%
Q3
16.99%
Median
9.28%
Q1
5.10%
Min
-12.52%

BDX’s Return on Equity of 6.31% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.

ORCL

66.28%

Software Industry

Max
66.28%
Q3
21.28%
Median
9.33%
Q1
-8.77%
Min
-48.16%

In the upper quartile for the Software industry, ORCL’s Return on Equity of 66.28% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

BDX vs. ORCL: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Net Profit Margin (TTM)

BDX

7.51%

Health Care Equipment & Supplies Industry

Max
24.41%
Q3
13.71%
Median
10.08%
Q1
5.96%
Min
-5.58%

BDX’s Net Profit Margin of 7.51% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.

ORCL

21.08%

Software Industry

Max
51.92%
Q3
19.23%
Median
6.98%
Q1
-7.14%
Min
-41.00%

A Net Profit Margin of 21.08% places ORCL in the upper quartile for the Software industry, signifying strong profitability and more effective cost management than most of its peers.

BDX vs. ORCL: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Operating Profit Margin (TTM)

BDX

11.83%

Health Care Equipment & Supplies Industry

Max
31.09%
Q3
18.11%
Median
15.07%
Q1
8.48%
Min
-0.28%

BDX’s Operating Profit Margin of 11.83% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

ORCL

30.44%

Software Industry

Max
60.40%
Q3
21.25%
Median
9.90%
Q1
-4.97%
Min
-43.50%

An Operating Profit Margin of 30.44% places ORCL in the upper quartile for the Software industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

BDX vs. ORCL: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Profitability at a Glance

SymbolBDXORCL
Return on Equity (TTM)6.31%66.28%
Return on Assets (TTM)2.90%7.56%
Net Profit Margin (TTM)7.51%21.08%
Operating Profit Margin (TTM)11.83%30.44%
Gross Profit Margin (TTM)45.08%69.66%

Financial Strength

Current Ratio (MRQ)

BDX

1.10

Health Care Equipment & Supplies Industry

Max
5.19
Q3
3.00
Median
2.13
Q1
1.44
Min
0.86

BDX’s Current Ratio of 1.10 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

ORCL

0.62

Software Industry

Max
4.29
Q3
2.37
Median
1.40
Q1
1.03
Min
0.25

ORCL’s Current Ratio of 0.62 falls into the lower quartile for the Software industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

BDX vs. ORCL: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Debt-to-Equity Ratio (MRQ)

BDX

0.76

Health Care Equipment & Supplies Industry

Max
1.61
Q3
0.76
Median
0.45
Q1
0.14
Min
0.00

BDX’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.76. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

ORCL

3.78

Software Industry

Max
2.16
Q3
0.86
Median
0.31
Q1
0.00
Min
0.00

With a Debt-to-Equity Ratio of 3.78, ORCL operates with exceptionally high leverage compared to the Software industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

BDX vs. ORCL: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Interest Coverage Ratio (TTM)

BDX

5.93

Health Care Equipment & Supplies Industry

Max
56.35
Q3
25.56
Median
9.60
Q1
3.78
Min
-26.49

BDX’s Interest Coverage Ratio of 5.93 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.

ORCL

4.92

Software Industry

Max
89.65
Q3
32.64
Median
1.00
Q1
-9.84
Min
-71.23

ORCL’s Interest Coverage Ratio of 4.92 is positioned comfortably within the norm for the Software industry, indicating a standard and healthy capacity to cover its interest payments.

BDX vs. ORCL: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Financial Strength at a Glance

SymbolBDXORCL
Current Ratio (MRQ)1.100.62
Quick Ratio (MRQ)0.460.50
Debt-to-Equity Ratio (MRQ)0.763.78
Interest Coverage Ratio (TTM)5.934.92

Growth

Revenue Growth

BDX vs. ORCL: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

BDX vs. ORCL: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

BDX

2.12%

Health Care Equipment & Supplies Industry

Max
4.15%
Q3
1.76%
Median
0.79%
Q1
0.00%
Min
0.00%

With a Dividend Yield of 2.12%, BDX offers a more attractive income stream than most of its peers in the Health Care Equipment & Supplies industry, signaling a strong commitment to shareholder returns.

ORCL

0.62%

Software Industry

Max
0.22%
Q3
0.11%
Median
0.00%
Q1
0.00%
Min
0.00%

ORCL’s Dividend Yield of 0.62% is exceptionally high, placing it well above the typical range for the Software industry. While this may seem attractive, an unusually high yield can sometimes be a warning sign, reflecting a falling stock price or market concerns about the dividend’s sustainability.

BDX vs. ORCL: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Dividend Payout Ratio (TTM)

BDX

73.10%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
66.60%
Median
27.49%
Q1
0.00%
Min
0.00%

BDX’s Dividend Payout Ratio of 73.10% is in the upper quartile for the Health Care Equipment & Supplies industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.

ORCL

40.62%

Software Industry

Max
3.29%
Q3
2.41%
Median
0.00%
Q1
0.00%
Min
0.00%

At 40.62%, ORCL’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Software industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.

BDX vs. ORCL: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Dividend at a Glance

SymbolBDXORCL
Dividend Yield (TTM)2.12%0.62%
Dividend Payout Ratio (TTM)73.10%40.62%

Valuation

Price-to-Earnings Ratio (TTM)

BDX

34.40

Health Care Equipment & Supplies Industry

Max
67.29
Q3
47.01
Median
30.94
Q1
23.91
Min
10.79

BDX’s P/E Ratio of 34.40 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

ORCL

65.29

Software Industry

Max
145.74
Q3
94.88
Median
45.35
Q1
26.66
Min
8.80

ORCL’s P/E Ratio of 65.29 is within the middle range for the Software industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

BDX vs. ORCL: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Price-to-Sales Ratio (TTM)

BDX

2.58

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.86
Q1
2.07
Min
0.74

BDX’s P/S Ratio of 2.58 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

ORCL

13.76

Software Industry

Max
25.67
Q3
13.68
Median
8.28
Q1
4.95
Min
0.90

ORCL’s P/S Ratio of 13.76 is in the upper echelon for the Software industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

BDX vs. ORCL: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Price-to-Book Ratio (MRQ)

BDX

1.94

Health Care Equipment & Supplies Industry

Max
10.85
Q3
6.56
Median
3.53
Q1
2.36
Min
0.71

BDX’s P/B Ratio of 1.94 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

ORCL

26.30

Software Industry

Max
30.67
Q3
14.92
Median
8.52
Q1
3.89
Min
0.38

ORCL’s P/B Ratio of 26.30 is in the upper tier for the Software industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

BDX vs. ORCL: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Software industry benchmarks.

Valuation at a Glance

SymbolBDXORCL
Price-to-Earnings Ratio (TTM)34.4065.29
Price-to-Sales Ratio (TTM)2.5813.76
Price-to-Book Ratio (MRQ)1.9426.30
Price-to-Free Cash Flow Ratio (TTM)21.6795.82